These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 34646020)
1. Structure of Venezuelan equine encephalitis virus in complex with the LDLRAD3 receptor. Basore K; Ma H; Kafai NM; Mackin S; Kim AS; Nelson CA; Diamond MS; Fremont DH Nature; 2021 Oct; 598(7882):672-676. PubMed ID: 34646020 [TBL] [Abstract][Full Text] [Related]
2. Structure of Venezuelan equine encephalitis virus with its receptor LDLRAD3. Ma B; Huang C; Ma J; Xiang Y; Zhang X Nature; 2021 Oct; 598(7882):677-681. PubMed ID: 34646021 [TBL] [Abstract][Full Text] [Related]
3. LDLRAD3 is a receptor for Venezuelan equine encephalitis virus. Ma H; Kim AS; Kafai NM; Earnest JT; Shah AP; Case JB; Basore K; Gilliland TC; Sun C; Nelson CA; Thackray LB; Klimstra WB; Fremont DH; Diamond MS Nature; 2020 Dec; 588(7837):308-314. PubMed ID: 33208938 [TBL] [Abstract][Full Text] [Related]
4. Entry receptor LDLRAD3 is required for Venezuelan equine encephalitis virus peripheral infection and neurotropism leading to pathogenesis in mice. Kafai NM; Janova H; Cain MD; Alippe Y; Muraro S; Sariol A; Elam-Noll M; Klein RS; Diamond MS Cell Rep; 2023 Aug; 42(8):112946. PubMed ID: 37556325 [TBL] [Abstract][Full Text] [Related]
5. 4.4 Å cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus. Zhang R; Hryc CF; Cong Y; Liu X; Jakana J; Gorchakov R; Baker ML; Weaver SC; Chiu W EMBO J; 2011 Aug; 30(18):3854-63. PubMed ID: 21829169 [TBL] [Abstract][Full Text] [Related]
6. Mutations in Hypervariable Domain of Venezuelan Equine Encephalitis Virus nsP3 Protein Differentially Affect Viral Replication. Meshram CD; Phillips AT; Lukash T; Shiliaev N; Frolova EI; Frolov I J Virol; 2020 Jan; 94(3):. PubMed ID: 31694937 [TBL] [Abstract][Full Text] [Related]
7. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses. Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563 [TBL] [Abstract][Full Text] [Related]
8. Locking and blocking the viral landscape of an alphavirus with neutralizing antibodies. Porta J; Jose J; Roehrig JT; Blair CD; Kuhn RJ; Rossmann MG J Virol; 2014 Sep; 88(17):9616-23. PubMed ID: 24920796 [TBL] [Abstract][Full Text] [Related]
9. Venezuelan equine encephalitis virus E1 protein interacts with PDIA6 and PDI inhibition reduces alphavirus production. Panny L; Akrhymuk I; Bracci N; Woodson C; Flor R; Elliott I; Zhou W; Narayanan A; Campbell C; Kehn-Hall K Antiviral Res; 2023 Apr; 212():105560. PubMed ID: 36822370 [TBL] [Abstract][Full Text] [Related]
11. Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection. Calvert AE; Bennett SL; Hunt AR; Fong RH; Doranz BJ; Roehrig JT; Blair CD Virology; 2022 Jan; 565():13-21. PubMed ID: 34626907 [TBL] [Abstract][Full Text] [Related]
12. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity. Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852 [TBL] [Abstract][Full Text] [Related]
13. Structural basis for VLDLR recognition by eastern equine encephalitis virus. Yang P; Li W; Fan X; Pan J; Mann CJ; Varnum H; Clark LE; Clark SA; Coscia A; Basu H; Smith KN; Brusic V; Abraham J Nat Commun; 2024 Aug; 15(1):6548. PubMed ID: 39095394 [TBL] [Abstract][Full Text] [Related]
14. Determining functionally important amino acid residues of the E1 protein of Venezuelan equine encephalitis virus. Negi SS; Kolokoltsov AA; Schein CH; Davey RA; Braun W J Mol Model; 2006 Sep; 12(6):921-9. PubMed ID: 16607494 [TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2. Chung DH; Jonsson CB; Tower NA; Chu YK; Sahin E; Golden JE; Noah JW; Schroeder CE; Sotsky JB; Sosa MI; Cramer DE; McKellip SN; Rasmussen L; White EL; Schmaljohn CS; Julander JG; Smith JM; Filone CM; Connor JH; Sakurai Y; Davey RA PLoS Pathog; 2014 Jun; 10(6):e1004213. PubMed ID: 24967809 [TBL] [Abstract][Full Text] [Related]
16. Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection. Phillips AT; Rico AB; Stauft CB; Hammond SL; Aboellail TA; Tjalkens RB; Olson KE J Virol; 2016 Jun; 90(12):5785-96. PubMed ID: 27053560 [TBL] [Abstract][Full Text] [Related]
18. Cryo-EM Structure of Chikungunya Virus in Complex with the Mxra8 Receptor. Basore K; Kim AS; Nelson CA; Zhang R; Smith BK; Uranga C; Vang L; Cheng M; Gross ML; Smith J; Diamond MS; Fremont DH Cell; 2019 Jun; 177(7):1725-1737.e16. PubMed ID: 31080061 [TBL] [Abstract][Full Text] [Related]
19. The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity. Hunt AR; Frederickson S; Maruyama T; Roehrig JT; Blair CD PLoS Negl Trop Dis; 2010 Jul; 4(7):e739. PubMed ID: 20644615 [TBL] [Abstract][Full Text] [Related]
20. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus. Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]